Page last updated: 2024-08-26

arctiin and Bone Loss, Osteoclastic

arctiin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, D; Chen, P; He, J; Kenny, J; Kuek, V; Liu, Y; Qiu, H; Wang, C; Wang, G; Wang, H; Wang, J; Wang, Q; Wang, Z; Xu, J; Yang, F; Ye, Z; Yuan, J; Zhang, G; Zhang, M1

Other Studies

1 other study(ies) available for arctiin and Bone Loss, Osteoclastic

ArticleYear
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
    Pharmacological research, 2020, Volume: 159

    Topics: Animals; Antioxidant Response Elements; Bone Density Conservation Agents; Bone Resorption; Calcium Signaling; Disease Models, Animal; Female; Furans; Glucosides; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; RAW 264.7 Cells; Reactive Oxygen Species

2020